Krassimir Mitchev
Chief Tech/Sci/R&D Officer chez CALLIDITAS THERAPEUTICS AB
Provenance du réseau au premier degré de Krassimir Mitchev
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 28 | |
| Public Company | Pharmaceuticals: Major | 23 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Krassimir Mitchev via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Treasurer Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Medical Specialties | Director/Board Member Chief Executive Officer | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| MEDA AB | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| RECIPHARM AB (PUBL) | Biotechnology | Director of Finance/CFO Public Communications Contact | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree | |
| Georgia State University | College/University | Graduate Degree Masters Business Admin | |
| Gettysburg College | College/University | Undergraduate Degree | |
| MEDCAP AB | Medical Specialties | Director/Board Member Director/Board Member | |
| Stockholm School of Economics | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Uppsala | College/University | Corporate Officer/Principal Doctorate Degree | |
| NEWRON PHARMACEUTICALS S.P.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Durham | College/University | Graduate Degree | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| WEIFA ASA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Lund | College/University | Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
| University of Oslo | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Chief Executive Officer Chief Operating Officer | |
TFS Trial Form Support AB
 TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
| VIVESTO AB | Pharmaceuticals: Generic | General Counsel Director/Board Member | |
Takeda Pharmaceuticals International AG
 Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Graduate Degree | |
European Biopharmaceutical Enterprises
 European Biopharmaceutical Enterprises BiotechnologyHealth Technology European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium. | Biotechnology | Director/Board Member | |
Nycomed AB
 Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal General Counsel | |
TFS Trial Form Support International AB
 TFS Trial Form Support International AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support International AB provides clinical contract research services. It offers clinical development planning, regulatory affairs, medical informatics, study and site coordination, clinical data management, biostatistics, medical writing, and other functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lud, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
| EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| Genzyme Danmark | Corporate Officer/Principal | ||
| WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
| SANA AB | Biotechnology | Chief Executive Officer | |
| MEREO BIOPHARMA GROUP PLC | Biotechnology | Corporate Officer/Principal | |
| AVROBIO, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| DOVA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| GENKYOTEX SA. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| GENERATION BIO CO. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| ROCKET PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Swedish Orphan Biovitrum, Inc.
 Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum, Inc. operates as an international rare disease company providing access to treatments that make a significant difference for people with rare diseases. Its business areas include haemophilia, immunology and specialty care. The company is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member President Director/Board Member | |
Kuste Biopharma SAS
 Kuste Biopharma SAS Pharmaceuticals: MajorHealth Technology Kuste Biopharma SAS engages in the development of therapies for unmet medical inflammatory. The company was founded in 2019 and is headquartered in Lyon, France. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Sobi, Inc. | Compliance Officer Corporate Officer/Principal |
Statistiques
Internationale
| Suède | 18 |
| Etats-Unis | 16 |
| Danemark | 7 |
| Royaume-Uni | 6 |
| Norvège | 3 |
Sectorielle
| Health Technology | 35 |
| Consumer Services | 11 |
| Commercial Services | 4 |
| Finance | 2 |
Opérationnelle
| Director/Board Member | 199 |
| Corporate Officer/Principal | 107 |
| Independent Dir/Board Member | 79 |
| Chairman | 60 |
| Chief Executive Officer | 37 |
Relations les plus connectées
| Insiders | |
|---|---|
| Sven Håkan Björklund | 46 |
| Bo Jesper Hansen | 34 |
| Elmar Schnee | 31 |
| Renée Aguiar-Lucander | 26 |
| Jeff Jonas | 21 |
| Fred Driscoll | 21 |
| Hilde Furberg | 21 |
| Guido Oelkers | 19 |
| Alan Henry Raffensperger | 17 |
| Lena Elisabeth Svanberg | 16 |
| Theresa Heggie | 16 |
| Henrik Stenqvist | 16 |
| Diane Parks | 14 |
| Birgitte Volck | 13 |
| Margareta Elisabeth Björk | 12 |
- Bourse
- Insiders
- Krassimir Mitchev
- Connexions Sociétés
